Hiroyuki Matsuda

Shizuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Reversible Pulmonary Mass Associated with Long-term Welding Fume Exposure: A Case Report.

Reversible Pulmonary Mass Associated with Long-term Welding Fume Exposure: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: August 26, 2026

Geriatric nutritional risk index in antifibrotic therapy can predict tolerability and mortality risk.

Geriatric nutritional risk index in antifibrotic therapy can predict tolerability and mortality risk.

Journal: Scientific reports

Published: January 14, 2026

Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD.

Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD.

Journal: Scientific reports

Published: August 20, 2025

Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic Therapy.

Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic Therapy.

Journal: Clinical lung cancer

Published: June 30, 2025

Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.

Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.

Journal: JTO clinical and research reports

Published: March 07, 2025

Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia.

Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia.

Journal: Scientific reports

Published: January 20, 2025

Association between the HAL score and the development of progressive pulmonary fibrosis in idiopathic interstitial pneumonia: A prospective observational study.

Association between the HAL score and the development of progressive pulmonary fibrosis in idiopathic interstitial pneumonia: A prospective observational study.

Journal: Respiratory investigation

Published: October 07, 2024

Prevalence and clinical features of progressive pulmonary fibrosis in patients with unclassifiable idiopathic interstitial pneumonia: A post hoc analysis of prospective multicenter registry.

Prevalence and clinical features of progressive pulmonary fibrosis in patients with unclassifiable idiopathic interstitial pneumonia: A post hoc analysis of prospective multicenter registry.

Journal: Respiratory investigation

Published: August 24, 2024

Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia.

Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia.

Journal: Scientific reports

Published: August 08, 2024

CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study.

CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study.

Journal: Respiratory research

Published: July 16, 2024

Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial.

Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 04, 2024

Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study.

Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study.

Journal: BMC pulmonary medicine

Published: March 16, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026